Metraipolis › archive › dc_e443a68e23ba

Natural Killer Cell Therapy in Ovarian Cancer: From Preclinical Potentials to Clinical Applications and Combination Strategies — Europe PMC PMID:42003913

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42003913
DOI
10.7150/ijbs.130260
License (as archived)
solo-consultazione
Archived
2026-11-04T08:10:02.611Z
SHA-256 of the archived text
ecb96c1f2198409674d9bcb3a8619682ecee52a69b9455806e70d73ffc708a00
Stable URL of this page
https://metraipolis.com/documento/dc_e443a68e23ba

How to cite

Natural Killer Cell Therapy in Ovarian Cancer: From Preclinical Potentials to Clinical Applications and Combination Strategies — Europe PMC PMID:42003913 — Europe PMC (en), https://europepmc.org/article/MED/42003913 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e443a68e23ba (Metraipolis archive dc_e443a68e23ba, sha256 ecb96c1f2198409674d9bcb3a8619682ecee52a69b9455806e70d73ffc708a00)
BibTeX
@misc{dce443a68e23ba,
  title = {Natural Killer Cell Therapy in Ovarian Cancer: From Preclinical Potentials to Clinical Applications and Combination Strategies — Europe PMC PMID:42003913},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42003913},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e443a68e23ba; sha256 ecb96c1f2198409674d9bcb3a8619682ecee52a69b9455806e70d73ffc708a00},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42003913. Agents can read the archived copy with the MCP tool read_document.